South Korea's Celltrion Inc. has signed an agreement to acquire Eli Lilly and Company's U.S. biopharmaceutical manufacturing facility, eliminating its tariff-related risks in the U.S. market. The purchase price was USD 330 million, as per a report by Pulse, the English service of Maeil Busi
Seoul [South Korea], December 29 (ANI/Global Economic): As SK Bioscience announced its plan to open a new R&PD center in Songdo, Incheon, three Korean bio companies called 'Big 3,' including Celltrion, Samsung Biologics, and SK Bioscience, are expected to gather in Songdo Bio-cluster.
Seoul [South Korea], May 12 (ANI/Global Economic): Worldwide sales of Regkirona (active ingredient: regdanvimab), a COVID-19 antibody drug developed by South Korean biopharmaceutical company Celltrion Inc, has begun.